Prescribing guidelines
Loading…
You will be guided to the Medicines Optimisation page. The relevant document should be top of the list
-
CVS: DOAC choice of stroke and systemic embolism prevention in adults with NVAF
Cardiovascular and Lipids
-
CVS: Furosemide (frusemide)- Guidance for prescribing Subcutaneous Furosemide
Cardiovascular and Lipids
Guidance for the assessment and treatment of end stage heart failure by subcutaneous furosemide for the treatment of symptomatic fluid overload
-
CVS: Hypertension Diagnosis and Management
Cardiovascular and Lipids
Endocrine and Diabetes
-
CVS: Lipid modification in younger adults with T2DM
Cardiovascular and Lipids
Endocrine and Diabetes
-
CVS: NOACS Management of bleeding with Direct Oral Anticoagulants
Cardiovascular and Lipids
Laboratory investigations and Infections
-
CVS: Spironolactone - Position Statement on MHRA Drug Safety Update
Cardiovascular and Lipids
-
CVS: Switching Between Oral Anticoagulants
Cardiovascular and Lipids
-
CVS: Ticagrelor guidelines
Cardiovascular and Lipids
-
Depression Management - antidepressant medication management in primary care
Brain and mental health
Did you find this page helpful?